Holdings
Cormorant Asset Management, LP
As of Jun 30, 2026, Cormorant Asset Management, LP reported 42 positions worth US$1.75B. Largest: Praxis Precision Medicines, Inc., Bridgebio Oncology Therapeutics, Inc. and Parabilis Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 640K | US$214M | −246K | Jun 30, 2026 |
| Bridgebio Oncology Therapeutics, Inc. | 17.9M | US$136M | no change | Jun 30, 2026 |
| Parabilis Medicines, Inc. | 4.62M | US$126M | new | Jun 30, 2026 |
| Rapport Therapeutics, Inc. | 2.66M | US$111M | −300K | Jun 30, 2026 |
| Erasca, Inc. | 6M | US$110M | +200K | Jun 30, 2026 |
| Edgewise Therapeutics, Inc. | 2.51M | US$102M | −750K | Jun 30, 2026 |
| Eyepoint, Inc. | 7M | US$100M | −1.26M | Jun 30, 2026 |
| Alumis Inc. | 3.29M | US$92.5M | −664K | Jun 30, 2026 |
| Abivax Sa | 675K | US$90M | −85,000 | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 750K | US$73.1M | −200K | Jun 30, 2026 |